Copyright Reports & Markets. All rights reserved.

Global Cannabinoid-based Antitumor Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Chewing Medicine
    • 1.2.3 Lozenge
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Cannabinoid-based Antitumor Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cannabinoid-based Antitumor Drug Market Perspective (2016-2027)
  • 2.2 Cannabinoid-based Antitumor Drug Growth Trends by Regions
    • 2.2.1 Cannabinoid-based Antitumor Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Cannabinoid-based Antitumor Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Cannabinoid-based Antitumor Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Cannabinoid-based Antitumor Drug Industry Dynamic
    • 2.3.1 Cannabinoid-based Antitumor Drug Market Trends
    • 2.3.2 Cannabinoid-based Antitumor Drug Market Drivers
    • 2.3.3 Cannabinoid-based Antitumor Drug Market Challenges
    • 2.3.4 Cannabinoid-based Antitumor Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cannabinoid-based Antitumor Drug Players by Revenue
    • 3.1.1 Global Top Cannabinoid-based Antitumor Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Cannabinoid-based Antitumor Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Cannabinoid-based Antitumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cannabinoid-based Antitumor Drug Revenue
  • 3.4 Global Cannabinoid-based Antitumor Drug Market Concentration Ratio
    • 3.4.1 Global Cannabinoid-based Antitumor Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cannabinoid-based Antitumor Drug Revenue in 2020
  • 3.5 Cannabinoid-based Antitumor Drug Key Players Head office and Area Served
  • 3.6 Key Players Cannabinoid-based Antitumor Drug Product Solution and Service
  • 3.7 Date of Enter into Cannabinoid-based Antitumor Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabinoid-based Antitumor Drug Breakdown Data by Type

  • 4.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2022-2027)

5 Cannabinoid-based Antitumor Drug Breakdown Data by Application

  • 5.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Cannabinoid-based Antitumor Drug Market Size (2016-2027)
  • 6.2 North America Cannabinoid-based Antitumor Drug Market Size by Type
    • 6.2.1 North America Cannabinoid-based Antitumor Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Cannabinoid-based Antitumor Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Cannabinoid-based Antitumor Drug Market Size by Type (2016-2027)
  • 6.3 North America Cannabinoid-based Antitumor Drug Market Size by Application
    • 6.3.1 North America Cannabinoid-based Antitumor Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Cannabinoid-based Antitumor Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Cannabinoid-based Antitumor Drug Market Size by Application (2016-2027)
  • 6.4 North America Cannabinoid-based Antitumor Drug Market Size by Country
    • 6.4.1 North America Cannabinoid-based Antitumor Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Cannabinoid-based Antitumor Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cannabinoid-based Antitumor Drug Market Size (2016-2027)
  • 7.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type
    • 7.2.1 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2016-2027)
  • 7.3 Europe Cannabinoid-based Antitumor Drug Market Size by Application
    • 7.3.1 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2016-2027)
  • 7.4 Europe Cannabinoid-based Antitumor Drug Market Size by Country
    • 7.4.1 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Type
    • 8.2.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Application
    • 8.3.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region
    • 8.4.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cannabinoid-based Antitumor Drug Market Size (2016-2027)
  • 9.2 Latin America Cannabinoid-based Antitumor Drug Market Size by Type
    • 9.2.1 Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Cannabinoid-based Antitumor Drug Market Size by Application
    • 9.3.1 Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Cannabinoid-based Antitumor Drug Market Size by Country
    • 9.4.1 Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type
    • 10.2.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application
    • 10.3.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country
    • 10.4.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Cannabics Inc.
    • 11.1.1 Cannabics Inc. Company Details
    • 11.1.2 Cannabics Inc. Business Overview
    • 11.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Introduction
    • 11.1.4 Cannabics Inc. Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.1.5 Cannabics Inc. Recent Development
  • 11.2 Tikun Olam
    • 11.2.1 Tikun Olam Company Details
    • 11.2.2 Tikun Olam Business Overview
    • 11.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Introduction
    • 11.2.4 Tikun Olam Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.2.5 Tikun Olam Recent Development
  • 11.3 Jay Pharma
    • 11.3.1 Jay Pharma Company Details
    • 11.3.2 Jay Pharma Business Overview
    • 11.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Introduction
    • 11.3.4 Jay Pharma Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.3.5 Jay Pharma Recent Development
  • 11.4 GW Pharmaceuticals
    • 11.4.1 GW Pharmaceuticals Company Details
    • 11.4.2 GW Pharmaceuticals Business Overview
    • 11.4.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Introduction
    • 11.4.4 GW Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.4.5 GW Pharmaceuticals Recent Development
  • 11.5 Medicanja Ltd
    • 11.5.1 Medicanja Ltd Company Details
    • 11.5.2 Medicanja Ltd Business Overview
    • 11.5.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Introduction
    • 11.5.4 Medicanja Ltd Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.5.5 Medicanja Ltd Recent Development
  • 11.6 Valeant Pharmaceuticals
    • 11.6.1 Valeant Pharmaceuticals Company Details
    • 11.6.2 Valeant Pharmaceuticals Business Overview
    • 11.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Introduction
    • 11.6.4 Valeant Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2016-2021)
    • 11.6.5 Valeant Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cannabinoid-based Antitumor Drug Scope and Market Size
    Cannabinoid-based Antitumor Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cannabinoid-based Antitumor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Chewing Medicine
    Lozenge
    Other

    Segment by Application
    Clinics
    Hospitals
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Cannabics Inc.
    Tikun Olam
    Jay Pharma
    GW Pharmaceuticals
    Medicanja Ltd
    Valeant Pharmaceuticals

    Buy now